University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Improvement of Outcomes in Draf III/Endoscopic Modified Lothrop Procedure

Not Applicable

Withdrawn

Conditions: Frontal Sinusitis
Chronic Sinusitis

Interventions: Device: Porcine Intestinal submucosal xenograft

First Posted Date: 2016-12-02

Last Posted Date: 2020-10-30

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT02981017

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States

MRA With Feraheme in HHT

Phase 1

Completed

Conditions: Hereditary Hemorrhagic Telangiectasia

Interventions: Procedure: Feraheme MRI/MRA

First Posted Date: 2016-11-30

Last Posted Date: 2019-01-25

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 10

Registration Number: NCT02977637

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Improving South African Government Workers' Capacities to Deliver HIV Interventions

Phase 2

Conditions: HIV
Partner Violence
Malnutrition
Alcohol Use/Abuse
Depression

Interventions: Behavioral: Control Condition
Behavioral: Accountable Condition

First Posted Date: 2016-11-08

Last Posted Date: 2021-10-14

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 840

Registration Number: NCT02957799

Locations: 🇿🇦
Stellenbosch University, Stellenbosch, South Africa
🇿🇦
Zithulele Hospital, Zithulele, South Africa

Effectiveness of Changing Dietary Fat on Weight Loss

Not Applicable

Completed

Conditions: Overweight

Interventions: Other: Haas Avocado
Behavioral: Dietary Counseling

First Posted Date: 2016-11-02

Last Posted Date: 2020-01-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 60

Registration Number: NCT02953158

Locations: 🇺🇸
UCLA Center for Human Nutrition, Los Angeles, California, United States

Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa

Completed

Conditions: Anxiety
Anorexia Nervosa, Restricting Type

Interventions: Other: fMRI

First Posted Date: 2016-10-28

Last Posted Date: 2023-05-31

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 66

Registration Number: NCT02948452

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Transfusion Using Stored Whole Blood

Conditions: Trauma
Hemorrhage
Coagulopathy

First Posted Date: 2016-10-06

Last Posted Date: 2017-10-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 98

Registration Number: NCT02926274

Locations: 🇺🇸
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States

Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates in New York State

Not Applicable

Completed

Conditions: Reminder System for Influenza Vaccines

Interventions: Behavioral: 1 Notice
Behavioral: 3 Notices
Behavioral: 2 Notices

First Posted Date: 2016-10-05

Last Posted Date: 2020-04-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 100000

Registration Number: NCT02924467

Contingency Management for Meth in South Africa Methamphetamine Abuse in South Africa

Not Applicable

Completed

Conditions: Methamphetamine Abuse

Interventions: Behavioral: Contingency Management

First Posted Date: 2016-09-20

Last Posted Date: 2019-05-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 28

Registration Number: NCT02907853

Locations: 🇿🇦
Department of Psychiatry at Groote Schuur Hospital, Cape Town, South Africa

Macitentan in the Treatment of Organ Rejection After Lung Transplantation

Phase 4

Withdrawn

Conditions: Lung Transplant Rejection

Interventions: Drug: placebo (for macitentan)
Drug: macitentan

First Posted Date: 2016-09-08

Last Posted Date: 2020-12-11

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT02893176

Locations: 🇺🇸
University of Califonia, Los Angeles, Los Angeles, California, United States

Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients

Phase 4

Completed

Conditions: Renal Transplant Rejection

Interventions: Drug: Prograf
Drug: Tacrolimus

First Posted Date: 2016-08-15

Last Posted Date: 2023-04-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 176

Registration Number: NCT02866682

Locations: 🇺🇸
UCLA Kidney Transplant Research, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy